Moody's Investors Service affirmed its "Baa3" rating for Oklahoma City-based OU Medicine, affecting $1.2 billion of debt.
The affirmation reflects the system's prominence as a large provider of high acuity services in the Oklahoma City area which will support strong demand and a good market position. The expansion of pediatric and adult beds over the next few years will allow the system to grow.
The rating outlook is stable.